Comorbid ASD in youth with ADHD is linked to greater healthcare utilization and distinct medication treatment patterns.

Cannabinoid therapies may alleviate agitation in Alzheimer disease, though somnolence remains a primary safety concern.

School bullying correlates with depression and internet addiction, but emotional resilience serves as a protective factor for adolescents.

Usual care in combination with Project Life Force lowers the risk for actual suicide attempts and improves coping skills in veterans with high risk.

The US Department of Health and Human Services Office of Inspector General reports on significant denial rates for post-hospital care.

Social determinants of health are associated with neurobiologic abnormalities in schizophrenia-spectrum psychotic conditions.

Middle-aged adults with positive plasma biomarkers for Alzheimer disease show accelerated decline in specific cognitive domains.

Viloxazine extended-release shows promise for treating adults with ADHD who also experience symptoms of depression and anxiety.

Nonmedical use of ADHD stimulants by adults is frequently motivated by a desire to improve concentration or stay alert and is often associated with other substance use disorders.

Childhood inattentive ADHD symptoms are associated with adverse occupational outcomes and higher stress levels in adulthood.

About a fourth of teens and adults with Tourette syndrome or another tic disorder have attempted suicide at some point in their lives.

Standardized diagnostic interviews show moderate-to-substantial test-retest reliability for adult psychiatric and substance use disorders.